Research output per year
Research output per year
Fingerprint
Dive into the research topics where Francesca Zoratto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status
Cortellini, A., Giusti, R., Filetti, M., Citarella, F., Adamo, V., Santini, D., Buti, S., Nigro, O., Cantini, L., Di Maio, M., Aerts, J. G. J. V., Bria, E., Bertolini, F., Ferrara, M. G., Ghidini, M., Grossi, F., Guida, A., Berardi, R., Morabito, A., Genova, C. & 29 others, , 2022, In: Journal of Hematology and Oncology. 15, 1, 9.Research output: Contribution to journal › Article › peer-review
-
Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078] (ESMO Open (2021) 6(2), (S205970292100034X), (10.1016/j.esmoop.2021.100078))
Banna, G. L., Cortellini, A., Cortinovis, D. L., Tiseo, M., Aerts, J. G. J. V., Barbieri, F., Giusti, R., Bria, E., Grossi, F., Pizzutilo, P., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., Macerelli, M., Rastelli, F., Chiari, R. & 26 others, , Jun 2021, In: ESMO Open. 6, 3, 100137.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Garrigós, L., Saura, C., Martinez-Vila, C., Zambelli, A., Bower, M., Pistilli, B., Lambertini, M., Ottaviani, D., Diamantis, N., Lumsden, A., Pernas, S., Generali, D., Seguí, E., Viñas, G., Felip, E., Sanchez, A., Rizzo, G., Santoro, A., Cortellini, A., Perone, Y. & 48 others, , 2021, In: Ther. Adv. Med. Oncol.. 13, p. 17588359211053416Research output: Contribution to journal › Article › peer-review
Open Access -
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Cortellini, A., Di Maio, M., Nigro, O., Leonetti, A., Cortinovis, D. L., Aerts, J. G. J. V., Guaitoli, G., Barbieri, F., Giusti, R., Ferrara, M. G., Bria, E., D'Argento, E., Grossi, F., Rijavec, E., Guida, A., Berardi, R., Torniai, M., Sforza, V., Genova, C., Mazzoni, F. & 41 others, , 2021, In: Journal for ImmunoTherapy of Cancer. 9, 4, e002421.Research output: Contribution to journal › Article › peer-review
-
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
Buti, S., Bersanelli, M., Perrone, F., Tiseo, M., Tucci, M., Adamo, V., Stucci, L. S., Russo, A., Tanda, E. T., Spagnolo, F., Rastelli, F., Pergolesi, F., Santini, D., Russano, M., Anesi, C., Giusti, R., Filetti, M., Marchetti, P., Botticelli, A., Gelibter, A. & 26 others, , 2021, In: European Journal of Cancer. 142, p. 18-28 11 p.Research output: Contribution to journal › Article › peer-review